0.779
cbdMD Inc stock is traded at $0.779, with a volume of 380.63K.
It is up +7.01% in the last 24 hours and up +9.72% over the past month.
See More
Previous Close:
$0.728
Open:
$0.711
24h Volume:
380.63K
Relative Volume:
0.42
Market Cap:
$8.18M
Revenue:
$19.09M
Net Income/Loss:
$-2.34M
P/E Ratio:
-0.3497
EPS:
-2.2277
Net Cash Flow:
$-2.13M
1W Performance:
+11.29%
1M Performance:
+9.72%
6M Performance:
-34.54%
1Y Performance:
-56.53%
cbdMD Inc Stock (YCBD) Company Profile
Compare YCBD vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
YCBD
cbdMD Inc
|
0.779 | 7.64M | 19.09M | -2.34M | -2.13M | -2.2277 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 56.39B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
120.76 | 50.93B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
9.66 | 43.19B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.61 | 36.99B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
577.58 | 25.36B | 3.18B | 1.33B | 1.04B | 27.90 |
cbdMD Inc Stock (YCBD) Latest News
cbdMD Updates Director Equity Awards and Compensation Structure - TipRanks
Growth Recap: Is cbdMD Inc stock a hidden gemEarnings Overview Summary & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Smart Money: Why is cbdMD Inc stock going downGap Down & Weekly Sector Rotation Insights - baoquankhu1.vn
Aug Action: Is cbdMD Inc attractive for institutional investorsTrade Risk Report & Stepwise Trade Execution Plans - baoquankhu1.vn
Forecast Cut: Will cbdMD Inc outperform tech stocksPortfolio Return Report & Weekly Sector Rotation Insights - baoquankhu1.vn
cbdMD Shareholders Approve Reverse Split and Capital Plans - The Globe and Mail
cbdMD, Inc. (YCBD-PA) Competitors - Meyka
YCBD Stock Price, Quote & Chart | CBDMD INC (NYSEARCA:YCBD) - ChartMill
cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare - Sahm
cbdMD shareholders approve equity plan, reverse stock split and director slate - Investing.com Australia
cbdMD shareholders approve equity plan, reverse stock split and director slate By Investing.com - Investing.com South Africa
cbdMD (NYSE: YCBD) shareholders approve 2025 equity plan and 445,000-share CEO award - Stock Titan
CbdMD, Inc. Announces Launch of Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare - marketscreener.com
Aug PreEarnings: Is cbdMD Inc in a bullish channel2026 Geopolitical Influence & High Conviction Trade Alerts - baoquankhu1.vn
Does cbdMD Inc have high return on assets2026 Historical Comparison & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Profit Recap: What are the future prospects of cbdMD IncPortfolio Update Summary & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Exit Recap: Can cbdMD Inc be the next market leader2026 Bull vs Bear & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Activity Recap: Is cbdMD Inc a good stock for dollar cost averaging2026 WrapUp & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Aug Mood: Is cbdMD Inc undervalued by DCF analysisTrade Ideas & Stepwise Trade Execution Plans - baoquankhu1.vn
If You Invested $1,000 in Cbdmd Inc (YCBD) - Stock Titan
Investment Report: Is cbdMD Inc attractive for institutional investorsWeekly Market Summary & Daily Entry Point Trade Alerts - baoquankhu1.vn
cbdMD, Inc. Common Stock (NY: YCBD - FinancialContent
Risk Off: Will cbdMD Inc outperform its industry peers2026 Chart Watch & High Yield Stock Recommendations - baoquankhu1.vn
Treasury Yields: Why is cbdMD Inc stock going downEntry Point & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Take Profit: Is cbdMD Inc attractive for institutional investors2026 Recap & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Revenue Check: Should I invest in cbdMD Inc before earnings2026 Rallies & Expert Approved Momentum Ideas - baoquankhu1.vn
History Review: Can cbdMD Inc. be the next market leaderInflation Watch & Stock Portfolio Risk Control - baoquankhu1.vn
Breakout Watch: What is the earnings history of cbdMD Inc2025 Performance Recap & Expert Curated Trade Ideas - baoquankhu1.vn
Will cbdMD Inc. stock rally after Fed decisionsJuly 2025 EndofMonth & Weekly High Return Stock Forecasts - Naître et grandir
cbdMD Q1 earnings preview - MSN
[EFFECT] cbdMD, Inc. SEC Filing - Stock Titan
cbdMD (YCBD) registers 2,000,000 conversion shares; no proceeds to issuer - Stock Titan
YCBD PE Ratio & Valuation, Is YCBD Overvalued - Intellectia AI
YCBDCbdmd Inc Latest Stock News & Market Updates - Stock Titan
Will cbdMD Inc. outperform its industry peersWeekly Profit Summary & AI Powered Market Entry Strategies - mfd.ru
How cyclical is cbdMD Inc.’s revenue streamJuly 2025 Retail & Fast Gain Stock Trading Tips - mfd.ru
What are the future prospects of cbdMD Inc.Market Performance Recap & Intraday High Probability Alerts - mfd.ru
Cbdmd Inc. Earnings Call Signals Cautious Recovery - The Globe and Mail
cbdMD, Inc. (AMEX:YCBD) Q1 2026 Earnings Call Transcript - Insider Monkey
cbdMD, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings Call Summary | CbdMD(YCBD.US) Q1 2026 Earnings Conference - 富途牛牛
cbdMD Inc (YCBD) Q1 2026 Earnings Call Highlights: Strategic Acquisitions and Financial ... By GuruFocus - Investing.com Canada
cbdMD reports narrowed Q1 net loss, issues going-concern warning - AlphaStreet News
cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026 - Finviz
MSN Money - MSN
cbdMD Q1 Earnings Report: What Investors Need to Know - Benzinga
CbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026 - 富途牛牛
Earnings Outlook For cbdMD - Benzinga
cbdMD (YCBD) Q1 Earnings Preview: EPS and Revenue Expectations - GuruFocus
Is cbdMD Inc. a top pick in the sector2025 Price Momentum & Accurate Trade Setup Notifications - mfd.ru
Will cbdMD Inc. benefit from government policyJuly 2025 Setups & Smart Swing Trading Alerts - mfd.ru
cbdMD Inc Stock (YCBD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):